Flow cytometric quantification of peripheral blood cell β-adrenergic receptor density and urinary endothelial cell-derived microparticles in pulmonary arterial hypertension

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Rose, Jonathan A ^a   Wanner, Nicholas ^b   Cheong, Hoi I ^b   Queisser, Kimberly ^b   Barrett, Patrick ^b   Park, Margaret ^b   Hite, Corrine ^b   Naga Prasad, Sathyamangla V ^b   Erzurum, Serpil ^b   Asosingh, Kewal ^b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRENOLOL; BETA ADRENERGIC RECEPTOR; BIOTIN; ISOPRENALINE; LIPOCORTIN 5; LOSARTAN; VASCULAR ENDOTHELIAL CADHERIN;

ADULT; ARTICLE; CARDIOVASCULAR PARAMETERS; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIAL MICROPARTICLE; FEMALE; FLOW CYTOMETRY; HEART RIGHT VENTRICLE FUNCTION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; MALE; PULMONARY HYPERTENSION; QUANTITATIVE ANALYSIS; TRICUSPID ANNULAR PLANE SYSTOLIC EXCURSION; URINALYSIS; URINE LEVEL; BLOOD; DRUG EFFECTS; LEUKOCYTE; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED;

ADULT; ALPRENOLOL; CELL-DERIVED MICROPARTICLES; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERTENSION, PULMONARY; LEUKOCYTES; MALE; MIDDLE AGED; RECEPTORS, ADRENERGIC, BETA;

EID: 84975252058     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0156940     Document Type: Article

References (45)

1. Haeck MLA, Vliegen HW. Diagnosis and treatment of pulmonary hypertension. Heart Br Card Soc. 2015; 101: 311-319. doi: 10.1136/heartjnl-2011-301386
2. Tonelli AR, Arelli V, Minai OA, Newman J, Bair N, Heresi GA, et al. Causes and circumstances of death in pulmonary arterial hypertension. Am J Respir Crit Care Med. 2013; 188: 365-369. doi: 10.1164/rccm.201209-1640OC PMID: 23600433
3. Masri FA, Xu W, Comhair SAA, Asosingh K, Koo M, Vasanji A, et al. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. AJP Lung Cell Mol Physiol. 2007; 293: L548-L554. doi: 10.1152/ajplung.00428.2006
4. Rockman HA, Koch WJ, Lefkowitz RJ. Seven-transmembrane-spanning receptors and heart function. Nature. 2002; 415: 206-212. doi: 10.1038/415206a PMID: 11805844
5. Kuriyama H, Ito Y, Suzuki H, Kitamura K, Itoh T. Factors modifying contraction-relaxation cycle in vascular smooth muscles. Am J Physiol. 1982; 243: H641-662. PMID: 6291410
6. Naga Prasad SV, Nienaber J, Rockman HA. Beta-adrenergic axis and heart disease. Trends Genet TIG. 2001; 17: S44-49. PMID: 11585676
7. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, et al. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982; 307: 205-211. doi: 10.1056/NEJM198207223070401 PMID: 6283349
8. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation. 1993; 87: 454-463. PMID: 8381058
9. Colucci WS, Alexander RW, Williams GH, Rude RE, Holman BL, Konstam MA, et al. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol. N Engl J Med. 1981; 305: 185-190. doi: 10.1056/NEJM198107233050402 PMID: 6113543
10. Brodde OE, Kretsch R, Ikezono K, Zerkowski HR, Reidemeister JC. Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. Science. 1986; 231: 1584-1585. PMID: 3006250
11. Hata JA, Williams ML, Schroder JN, Lima B, Keys JR, Blaxall BC, et al. Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading. J Card Fail. 2006; 12: 360-368. doi: 10.1016/j.cardfail.2006.02.011 PMID: 16762799
12. Williams LT, Snyderman R, Lefkowitz RJ. Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding. J Clin Invest. 1976; 57: 149-155. doi: 10.1172/JCI108254 PMID: 1245597
13. Bauer N, Hargett L. On the origin of microparticles: From "platelet dust" to mediators of intercellular communication. Pulm Circ. 2013; 3: 329. doi: 10.4103/2045-8932.114760 PMID: 24015332
14. Barteneva NS, Fasler-Kan E, Bernimoulin M, Stern JN, Ponomarev ED, Duckett L, et al. Circulating microparticles: square the circle. BMC Cell Biol. 2013; 14: 23. doi: 10.1186/1471-2121-14-23 PMID: 23607880
15. Bernal-Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J. 2003; 145: 962-970. doi: 10.1016/S0002-8703(03)00103-0 PMID: 12796750
16. Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension. 2006; 48: 180-186. doi: 10.1161/01.HYP.0000231507.00962.b5 PMID: 16801490
17. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, et al. Circulating Endothelial Microparticle Levels Predict Hemodynamic Severity of Pulmonary Hypertension. Am J Respir Crit Care Med. 2008; 177: 1268-1275. doi: 10.1164/rccm.200710-1458OC PMID: 18310479
18. Martinez MC, Andriantsitohaina R. Microparticles in Angiogenesis: Therapeutic Potential. Circ Res 2011; 109: 110-119. doi: 10.1161/CIRCRESAHA.110.233049 PMID: 21700952
19. Curtis AM, Edelberg J, Jonas R, Rogers WT, Moore JS, Syed W, et al. Endothelial microparticles: Sophisticated vesicles modulating vascular function. Vasc Med. 2013; 18: 204-214. doi: 10.1177/1358863X13499773 PMID: 23892447
20. Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2010; 23: 685-713; quiz 786-788. doi: 10.1016/j.echo.2010.05.010
21. Chow S, Hedley D, Grom P, Magari R, Jacobberger JW, Shankey TV. Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations. Cytom Part J Int Soc Anal Cytol. 2005; 67: 4-17. doi: 10.1002/cyto.a.20167
22. Chow S, Hedley D, Shankey TV. Whole blood processing for measurement of signaling proteins by flow cytometry. Curr Protoc Cytom Editor Board J Paul Robinson Manag Ed Al. 2008;Chapter 9: Unit 9.27. doi: 10.1002/0471142956.cy0927s46
23. Inglis HC, Danesh A, Shah A, Lacroix J, Spinella PC, Norris PJ. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry. Cytom Part J Int Soc Anal Cytol. 2015; 87: 1052-1063. doi: 10.1002/cyto.a.22649
24. Inglis HC, Danesh A, Shah A, Lacroix J, Spinella PC, Norris PJ. Techniques to improve detection and analysis of extracellular vesicles using flow cytometry: Accuracy and Efficiency of EV Detection Using FCM. Cytometry A. 2015; 87: 1052-1063. doi: 10.1002/cyto.a.22649 PMID: 25847910
25. Meier KE, Ruoho AE. Formation of complexes between avidin and beta-adrenergic receptors using biotinyl-alprenolol derivatives. Biochim Biophys Acta. 1983; 761: 257-261. PMID: 6317049
26. Bull TM, Golpon H, Hebbel RP, Solovey A, Cool CD, Tuder RM, et al. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost. 2003; doi: 10.1160/TH03-04-0251
27. Smadja DM, Mauge L, Sanchez O, Silvestre J-S, Guerin C, Godier A, et al. Distinct patterns of circulating endothelial cells in pulmonary hypertension. Eur Respir J. 2010; 36: 1284-1293. doi: 10.1183/09031936.00130809 PMID: 20413531
28. Witwer KW, Buzás EI, Bemis LT, Bora A, Lässer C, Lötvall J, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013; 2. doi: 10.3402/jev.v2i0.20360
29. Van Der Pol E, Coumans FAW, Sturk A, Nieuwland R, Van Leeuwen TG. Refractive index determination of nanoparticles in suspension using nanoparticle tracking analysis. Nano Lett. 2014; 14: 6195-6201. doi: 10.1021/nl503371p PMID: 25256919
30. Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006; 174: 1034-1041. doi: 10.1164/rccm.200604-547OC PMID: 16888289
31. Asosingh K, Farha S, Lichtin A, Graham B, George D, Aldred M, et al. Pulmonary vascular disease in mice xenografted with human BM progenitors from patients with pulmonary arterial hypertension. Blood. 2012; 120: 1218-1227. doi: 10.1182/blood-2012-03-419275 PMID: 22745307
32. Farha S, Asosingh K, Xu W, Sharp J, George D, Comhair S, et al. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood. 2011; 117: 3485-3493. doi: 10.1182/blood-2010-09-306357 PMID: 21258008
33. Lanzola E, Farha S, Erzurum SC, Asosingh K. Bone marrow-derived vascular modulatory cells in pulmonary arterial hypertension. Pulm Circ. 2013; 3: 781-791. doi: 10.1086/674769 PMID: 25006394
34. Yan L, Jia Z, Cui J, Yang H, Yang H, Zhang Y, et al. Beta-adrenergic signals regulate cardiac differentiation of mouse embryonic stem cells via mitogen-activated protein kinase pathways. Dev Growth Differ. 2011; 53: 772-779. doi: 10.1111/j.1440-169X.2011.01284.x PMID: 21711454
35. Fan X, Wang Y. β2 Adrenergic receptor on T lymphocytes and its clinical implications. Prog Nat Sci. 2009; 19: 17-23. doi: 10.1016/j.pnsc.2008.10.001
36. Méndez-Ferrer S, Battista M, Frenette PS. Cooperation of beta(2)- and beta(3)-adrenergic receptors in hematopoietic progenitor cell mobilization. Ann N Y Acad Sci. 2010; 1192: 139-144. doi: 10.1111/j.1749-6632.2010.05390.x PMID: 20392229
37. Bristow MR, Minobe W, Rasmussen R, Larrabee P, Skerl L, Klein JW, et al. Beta-adrenergic neuroeffector abnormalities in the failing human heart are produced by local rather than systemic mechanisms. J Clin Invest. 1992; 89: 803-815. doi: 10.1172/JCI115659 PMID: 1311717
38. Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984; 311: 819-823. doi: 10.1056/NEJM198409273111303 PMID: 6382011
39. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure? Circ Res. 2003; 93: 896-906. doi: 10.1161/01.RES.0000102042.83024.CA PMID: 14615493
40. Yáñez-Mó M, Siljander PR-M, Andreu Z, Zavec AB, Borràs FE, Buzas EI, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015; 4: 27066. doi: 10.3402/jev.v4.27066 PMID: 25979354
41. Erdbrügger U, Lannigan J. Analytical challenges of extracellular vesicle detection: A comparison of different techniques. Cytom Part J Int Soc Anal Cytol 2016; 89: 123-134. doi: 10.1002/cyto.a.22795
42. Mezentsev A, Merks RMH, O'Riordan E, Chen J, Mendelev N, Goligorsky MS, et al. Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol. 2005; 289: H1106-1114. doi: 10.1152/ajpheart.00265.2005 PMID: 15879485
43. Bretelle F, Sabatier F, Desprez D, Camoin L, Grunebaum L, Combes V, et al. Circulating microparticles: a marker of procoagulant state in normal pregnancy and pregnancy complicated by preeclampsia or intrauterine growth restriction. Thromb Haemost. 2003; 89: 486-492. doi: 10.1267/THRO03030486 PMID: 12624632
44. Brodsky SV, Zhang F, Nasjletti A, Goligorsky MS. Endothelium-derived microparticles impair endothelial function in vitro. Am J Physiol Heart Circ Physiol. 2004; 286: H1910-1915. doi: 10.1152/ajpheart.01172.2003 PMID: 15072974
45. Jimenez JJ, Jy W, Mauro LM, Horstman LL, Soderland C, Ahn YS. Endothelial microparticles released in thrombotic thrombocytopenic purpura express von Willebrand factor and markers of endothelial activation. Br J Haematol. 2003; 123: 896-902. PMID: 14632781